Use of the FIM instrument in a trial of intramuscular interferon β-1a for disease progression in relapsing-remitting multiple sclerosis

Use of the FIM instrument in a trial of intramuscular interferon β-1a for disease progression in relapsing-remitting multiple sclerosis

Saved in:
Bibliographic Details
Published in:American journal of physical medicine & rehabilitation Vol. 82; no. 6; pp. 427 - 436
Main Authors: GRANGER, Carl V, WENDE, Karl, BROWNSCHEIDLE, Carol M
Format: Journal Article
Language:English
Published: Baltimore, MD Lippincott 01-06-2003
Subjects:
Biological and medical sciences
Medical sciences
Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
Neurology
Measurement
Relapse
Multiple sclerosis
Questionnaire
Methodology
Mobility
Cognition
Route of administration
Intramuscular administration
Inflammatory disease
Activities of Daily Living
Interferon β-1a
Clinical trial
Remission
Human
Disability Evaluation
Nervous system diseases
Evaluation scale
Daily living
Treatment efficiency
Relapsing-Remitting Multiple Sclerosis
Chemotherapy
Treatment
Central nervous system disease
Interferon
Disabled Persons
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0894-9115
1537-7385
DOI:10.1097/01.PHM.0000069189.86581.08